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The urinary tract is the most common site of nosocomial infections accounting for more than 
40% of the total number reported by acute care hospitals and affecting approximately 600,000 
patients per year. Catheter Associated Urinary Tract Infection (CAUTI) defines in terms of 
“bacteriuria” and “urinary tract infection” frequently. Bacteriuria or funguria levels >103 
colony- forming units (CFU) have been shown to be highly predictive of CAUTI, given that 
these levels increase to 105 CFU within 24 to 48 hours. In Indian population, catheter-
associated urinary tract infection (CAUTI) is an important cause of morbidity and mortality, 
affecting all age groups. Biofilm is the predominant mode of growth in aquatic ecosystems 
and, as such, plays a central role in the pathogenesis of Catheter Associated Urinary Tract 
Infections (CAUTI). The present review focuses to evaluate the incidence and pattern of 
microbes in catheter associated urinary tract infection and provides information about the 
etiology of CAUTI. Most of the studies concluded that gram negative pathogen E.coli showed 
the highest incidence rate and other pathogens like Klebsiella pneumonia, Pseudomonas 
aeruginosa, and staphylococcus species also having the incidence rate in the patient having 
CAUTI. The antibiotic resistance pattern showed the variation in resistance and sensitivity of 
antibiotics against the pathogens. The present study focuses on the incidence of the microbial 
growth in patient having catheterization and also elucidates the antibiotic sensitivity pattern. It 




The urinary tract is the most common site of nosocomial 
infections accounting for more than 40% of the total number 
reported by acute care hospitals and affecting approximately 
600,000 patients per year. Sixty six percent to 86% of these 
infections usually follow instrumentation of urinary tract, 
mainly catheterization. The risk of acquiring a urinary tract 
infection (UTI) depends on method and duration of 
catheterization, the quality of catheter care and host 
susceptibility. [1] 
 
Catheter Associated Urinary Tract Infection (CAUTI) defines 
in terms of “bacteriuria” and “urinary tract infection” 
frequently. [2] Bacteriuria or funguria levels >103 colony- 
forming units (CFU) have been shown to be highly predictive 
of CAUTI, given that these levels increase to 105 CFU within 
24 to 48 hours. [3]  
The 2009 Infectious Diseases Society of America (IDSA) 
guidelines define CA-UTI as “the presence of symptoms or 
signs compatible with UTI with no other identified source of 
infection along with ≥103 colony-forming units (cfu)/mL of 
≥1 bacterial species” from a catheterized or previously 
catheterized (≤48 hours) urine sample.[4] 
 
Signs and symptoms associated with CAUTI such as fever, 
disuria, urgency, flank pain and leukocytosis have also been 
shown to have a low positive predictive value for CAUTI 
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diagnosis since 90% of them are asymptomatic. A catheter in 
the urethra also prevents continuous urethral exposure to large 
numbers of organisms in the infected urine, averting urethritis, 
and consequently, urgency and disuria. [5] Millions Of urinary 
tract catheterizations are carried out worldwide for purposes of 
control, repair, diagnosis and treatment. The risk of infection 
per procedure is from 1 to 2%. This risk increases to 3 to 7% 
per catheterization day in such a way that nearly all patients 
will present with bacteriuria after 30 days of urethral 
catheterization. [6] 
 
Catheter Associated Urinary Tract Infections, the most 
common type of nosocomial infection, account for over 1 
million cases annually also elucidated from the recent study. 
[7] Some other studies focuses that the daily incidence of 
bacteriuria is 3-10%, after catheterization. Between 10% and 
30% of patients who undergo short-term catheterization (ie, 2-
4 days) develop bacteriuria and are asymptomatic. Between 
90% and 100% of patients who undergo long-term 
catheterization develop bacteriuria. About 80% of nosocomial 
UTIs are related to urethral catheterization; only 5-10% 
related to genitourinary manipulation. [8] 
 
In Indian population, catheter-associated urinary tract 
infection (CAUTI) is an important cause of morbidity and 
mortality, affecting all age groups. [9] Bacteriuria or 
candiduria is almost inevitable in nearly half of the patients 
who require an indwelling urinary catheter for more than 5 
days. [2][10] 
Asymptomatic bacteriuria constitutes a major pool of the 
antibiotic-resistant strains of pathogens with critical care units. 
[11] CAUTI is also a major cause of hospital-acquired 
bacteraemia, [12] that may be associated with enhanced in-
hospital mortality rates. 
 
CAUTI is usually deemed present if there are at least 103 
colony-forming units (cfu)/mL of 1 or 2 micro-organisms 
identified by urine culture. [13] While 'significant’ bacteriuria 
is defined as >105 cfu/mL, once micro-organisms are detected 
in the urine, in the absence of anti-microbials, it is almost 
inevitable to reach the 105 cfu/mL level quite rapidly. An ICU-
acquired UTI refers to those patients who develop a positive 
urine culture first identified on ICU Day 3 (48 h) or later. [14] 
Patients developing positive urine cultures within 48 h of 
being discharged from an ICU could also be defined as having 
ICU-acquired UTI.  
 
The Centers for Disease Control and Prevention (CDC) 
defines CAUTI for those patients who have an indwelling 
catheter in place for 48 h or more. [15] For diagnosing UTI, 
the CDC requires that the patient should be manifesting 
symptoms such as fever or chills, new onset of burning pain, 
urgency or frequency if not catheterized at that point of time, 
change in urine character, flank or suprapubic pain or 





To understand the pathogenesis of infection of the catheter 
associated, it is necessary to understand the formation of 
biofilm on the surface of catheter. The formation of bacterial 
biofilms on surfaces appears to be a universal bacterial 
strategy for survival in both nature and disease. [16] Recent 
evidence indicates that bacterial biofilms might also be 
involved in biomaterial-related bacterial infections 
A biofilm is not a static, filmy slime layer but rather is a living 
organism composed of multiple species of bacteria and their 
secreted polysaccharide matrix and components deposited 
from bodily fluids. [17] 
 
Catheter are a good medium of bacterial growth because once 
they gain entry in the urinary tract, bacteria produce various 
adhesions that allow them to attached with the catheter wall 
and that leads to formation of biofilms. Biofilm is the 
predominant mode of growth in aquatic ecosystems and, as 
such, plays a central role in the pathogenesis of Catheter 
Associated Urinary Tract Infections (CAUTI). Most aspects of 
the diagnosis, treatment, and prevention of CAUTI are 
influenced by the tenacity of biofilm-associated uropathogens. 
The biofilm mode of living is a highly advantageous response 
of the micro-organisms to the environmental stresses of the 
urinary tract environment. [18] 
 
The first step in formation of catheter-associated biofilm is 
deposition of a conditioning film on the surface of the device. 
It is generally accepted that bacteria gain entrance to the 
bladder from retrograde intra luminal ascent of organisms 
from contaminated open collection vessels in the early days, 
[19] from the collecting bag or disconnected catheter drainage 
tube junction since the introduction of the closed urinary 
drainage system, [20] and extra luminally from a colonized 
urethral meatus if strict sterile closed drainage is maintained. 
[21][22] The biofilm protects the organism from the 
antimicrobials and the host immune response. [23] 
 
Observations in animal models of the closed catheter drainage 
system have disclosed that bacteria form thick coherent 
biofilms adherent to experimentally contaminated drainage 
spouts extending proximally into the drainage bag and 
subsequently into the catheter. [24][25] Employing a 
bacteriologically stressed animal model of short term 
catheterization (fewer than seven days), contamination of the 
drainage spout or accidental disconnection of the drainage 
tube resulted in bacteriuria within a short time (32 to 48 h). If 
a strict sterile closed drainage system was maintained and the 
urethral meatus-catheter junction was inoculated, the 
extraluminal route would assume greater importance in the 
development of bacteriuria: however, this pathway was 
considerably slower (72 to 168 h). These findings regarding 
the relative importance of the intraluminal and extraluminal 
periurethral routes were confirmed in further animal model 
studies employing a microbicidal hurdle or barrier in the outlet 
tube of the drainage bag. [26][27]  
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In in-vitro system, it could be demonstrated that the bacteria 
were ascending the surface of the catheter in a coherent 
biofilm containing bacterial cells in their secretory products or 
glycocalyx. 
In the absence of antibiotics it appeared that the ascending 
bacterial biofilm was moving by two mechanisms:  
 
1. Rapidly dividing bacterial cells spreading along the 
catheter surface within the glycocalyx material of the 
biofilm.   
2. Planktonic or floating bacterial cells within the urine 
column leapfrogging just ahead of the adherent 
biofilm, perhaps assisted by the turbulence caused 
when the urine flow meets the biofilm front. 
 
The movement of ‘saltatory’ bacteria may allow some bacteria 
to establish adherent microcolonies ahead of the ascending 
biofilm, which expand with the main bacterial aggregate into 
the ascending coherent biofilm. [28] 
 
Planktonic bacteria being released from the biofilm adherent 
to the Foley catheter can be easily demonstrated in aspirated 
urine cultures: however, at this point the bacteria are 
colonizing only the catheter surface. The intravesical segment 
of the Foley catheter eventually becomes covered with a much 
thicker colonizing adherent bacterial aggregate enclosed 
within the bacterial slime matrix. This macroscopic bacterial 
biofilm can create flow kinetic problems by partially blocking 
catheter islets and reducing the tubular diameter of the catheter 
lumen. This biofilm-induced disruption of effective urine flow 
may increase the volume and perhaps pressure of the residual 
urine that is always present in catheterized bladders. [29] 
 
A thin blanket of mucus or glycosaminoglycan coats the 
bladder mucosal surface and appears to inhibit bacterial 
adherence to the uroepithelium. The indwelling Foley catheter 
appears to disrupt this bladder mucus or glycosaminoglycan 
layer and causes mechanical irritation and even erosion of the 
bladder mucosa, exposing surfaces that allow bacterial 
adherence. [30] Once the organisms gain access to the 
catheterized urinary tract, the level of bacteriuria usually 
increases to more than 105 cfu/mL within 24 to 48 hours in the 
absence of antimicrobial therapy. The presence of urinary 
catheter alters the physiology of the urinary tract and 
predisposes the individual to infection. [4] 
Biofilms have major medical significance as they decrease 
susceptibility to antimicrobial agents. The decreased 
susceptibility to microbial agents within a biofilm arises from 
multiple factors, including physical impairment of diffusion of 
antimicrobial agents, reduced bacterial growth rates, and local 
alterations of the microenvironment that may impair activity 
of the antimicrobial agent. Furthermore, the proximity of cells 
within a biofilm can facilitate plasmid exchange and hence 
enhance the spread of antimicrobial resistance. [31] 
 
This review also focuses to evaluate the incidence and pattern 
of microbes in catheter associated urinary tract infection and 
provides information about the etiology of CAUTI. 
 
Microbial growth incidence 
 
The pattern of microbial growth in catheter associated urinary 
tract infection patients approximately very common, there 
may be gram positive or gram negative activity that causes the 
biofilm formation leads to infection.  
  
Enteric pathogens (eg, Escherichia coli) are most commonly 
responsible, but Pseudomonas species, Enterococcus species, 
Staphylococcus aureus, coagulase-negative staphylococci, 
Enterobacter species, and yeast also are known to cause 
infection. Proteus and Pseudomonas species are the organisms 
most commonly associated with biofilm growth on catheters. 
[8] 
 
Uropathogenic Escherichia coli (UPEC), the primary cause of 
community-acquired urinary tract infections (UTIs), account 
for 50% of nosocomial UTIs, including CAUTIs. [32] After 
urinary catheterization, the pathogenesis E.coli results in 
disruption of the normal mechanical and antimicrobial 
defenses of the bladder. [33] UPEC strains and other 
uropathogens must attach to uroepithelial cells and the 
catheter surface to colonize and initiate CAUTI and may 
express a variety of adhesins to assist in this initial attachment. 
These adhesins also contribute to the direct triggering of host 
and bacterial signaling pathways, assisting in the delivery of 
bacterial products to host tissues, and promoting bacterial 
invasion into host cells. [34] 
 
Proteus species are the causative organism for the catheter 
associated urinary tract infection. Colonization of the 
intestinal tract allows Proteus to establish reservoirs for 
transmission into the urinary tract by intermittent colonization 
of the periurethral region. This intermittent colonization can 
lead to the subsequent contamination of the catheter, thus 
allowing nosocomial infections to develop. [35] The three 
species of Proteus associated with UTIs are Proteus mirabilis, 
Proteus vulgaris, and Proteus penneri. Proteus mirabilis is the 
third most common cause of complicated UTI (12%) and the 
second most common cause of catheter-associated bacteriuria 
in patients catheterized long term (15%). [36] 
 
Other most frequent causative agents of catheter associated 
urinary tract infection include Klebsiella pneumoniae, 
pseudomonas aeruginosa, Enterococci species and 
staphylococci species. Klebsiella pneumoniae is a gram 
negative bacteria mainly involved in Enterococci species. 
Recent studies found the causative uropathogens responsible 
for the infection in which, E.coli was found to be the most 
frequently isolated uropathogen in 70%, followed by 
Klebsiella pneumoniae 16%, Pseudomonas aeruginosa 4%, 
Acinetobacter spp 2%, coagulase negative Staphylococci 6% 
and Enterococci Spp 2%. [18] 
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Study at Nigeria showed that early onset of UTI had 
developed for 4 days at the ICU and late onset developed for 5 
days after at the ICU admission and  microorganism 
responsible for urinary catheter related infection, were the 
following, E. coli (16%), Pseudomonas aeruginosa (7%), 
Morganella morgani (4 %), Klebsiella (4 %), Citrobacter 
(4%), Proteus mirabilis (3%), Enteroccocus feacalis and 
coagulase negative Staphylocococus (7%,), Candida (12%] 
and other fungi, stating that most Urinary Catheter Related 
Infection had a late onset of the infection which was caused by 
only certain organism and were mainly due to E.coli and C. 
Albicans. [37] 
 
Prevention of CAUTI 
 
According to CDC guidelines the catheter associated urinary 
tract infection preventive measures categorised in two main 
categories i.e. Category I (Strongly recommended), Category 
II (Moderately recommended). [38] Both the categories 
emphasis on the prevention of CAUTI.  
 
Category I: 
• Catheterize only when necessary. 
• Educate personnel in correct techniques of catheter 
insertion and care. 
• Emphasize hand washing. 
• Insert catheter using aseptic technique and sterile 
equipment. 
• Secure catheter properly. 
• Maintain closed sterile drainage. 
• Obtain urine specimens aseptically. 
• Maintain unobstructed urine flow. 
 
Category II: 
• Periodically re-educate personnel in catheter care. 
• Use smallest suitable catheter bore. 
• Avoid irrigation unless needed to prevent or relieve 
obstruction. 
• Refrain from daily meatal care. 
• Do not change catheters at arbitrary intervals. 
 
In term of delaying the bacteriuria, the preventive strategies 
categories as effective, possibly effective, effective only for 
short-term catheterization, ineffective, and novel approaches.  
Effective strategies include closed drainage and catheter 
removal. Closed drainage, in which the collection tube is fused 
to the drainage bag, reduces the incidence of bacteriuria. In 
possible effective strategies, a system maintained to remind 
the physician who among their patients has urinary catheters 
might shorten the duration of catheterization and, thus, 
decrease the incidence of CAUTI. The strategies changing 
catheter materials to render the catheter surface inhospitable to 
biofilm formation is a clever idea, this approach is effective 
for prevention of UTI only in the setting of short-term 
catheterization. Use of antimicrobial agents, either 
systemically or inserted directly into bladder are the strategies 
that have proven ineffective for prevention of CAUTI. The 
novel approach strategies include Disrupt quorum sensing, 
Iron scavenging catheters, Bacterial interference showed the 
effectiveness towards the catheter associated urinary tract 
infection. [39] 
For the prevention of catheter associated urinary tract 
infection, it is necessary to shorten the duration of catheter and 
examine the regular culture for the detection of incidence of 
microbial growth and also elucidate the antibiotic sensitivity 
pattern. The specific antibiotic used according to sensitivity 
report. Catheter associated urinary tract infection preventive 





The availability of antibiotic is remarkable and new agents are 
frequently added. But now a day’s bacteria develops 
resistance, including methods that may decrease the 
intracellular concentrations of the antibiotic, deactivate the 
antibiotic, change the binding sites for the antibiotic, and 
develop adaptations that bypass the need for the binding site 
targeted by the antibiotic. [40]  
From the previous study it was clearly showed that bacterial 
uropathogen isolates from patients with UTIs revealed the 
presence of high levels of single and multiple antimicrobial 
resistances against commonly prescribed drugs. E. coli which 
is the predominant cause of UTI, showed high percentage of 
resistance to ampicillin and amoxacillin (100%), and low 
resistance to ciprofloxacin (14.3%). Klebsiella spp which is 
the second most prevalent pathogen of UTI displayed a similar 
resistance pattern as of E.coli and showed hundred percent 
resistant to ampicillin and amoxicillin; however, all isolates 
were susceptible to ciprofloxacin and all others gram negative 
isolates were similarly resistant to ampicillin and amoxicillin 
as to that of E. coli and K. Pneumonia.[41] 
Another study from India also showed that 80% resistance to 
nalidixic acid, ampicillin, cephotaxime and Cotrimoxazole. 
The study also elucidates that there is a correlation between 
biofilm production and resistance to multiple antibiotics. 
Therapy against UTI should be guided by antimicrobial 
susceptibilities as increasing numbers of urinary isolates are 
developing resistance to commonly used antibiotics. The 
therapy used for the catheter associated urinary tract infection 
used after the antibiotic sensitivity test performed that helps in 
knowing the resistance and sensitivity of antibiotic against the 
microorganisms. [18] 
Study at Nigeria elucidates that the gram negative organisms 
such as E.Coli etc showed high resistance to commonly used 
antibiotics such as ampicillin (100%), gentamicin (90.9%), 
tetracycline (89.1%), cotrimoxazole (87.3%), cefuroxime 
(81.1%), nalidixic acid (87.3%), nitrofurantoin (67.3%), 
colistin (63.7%), perfloxacin (65.5%) and ciprofloxacin 
(56.4%). Staphylococcus aureus isolates were also resistant to 
penicillin (100%), gentamicin (100%), cotrimoxazole (100%), 
chloramphenicol (100%), cloxacillin (83.3%), tetracycline 
(83.3%), erythromycin (66.7%) and cefuroxime (66.7%). Only 
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perfloxacin (66.7% sensitivity) and ciprofloxacin (83.3% 
sensitivity) appear effective. This highly antibiotic resistance 
pattern showed that poorly guided antibiotic pattern to the 
patient after and during the catheterization. The study focuses 
on the properly prescribed antibiotic and also examines the 
antibiotic sensitivity test with the microbial incidence. [1] 
Recent study at a teaching hospital examines that gram 
negative bacteria E.coli showed highly susceptibility towards 
Cotrimoxazole and other 1st line drugs. Pseudomonas 
aeruginosa, which is most common cause of hospital-acquired 
UTI, was less sensitive to quinolones and cephalosporin than 
aminoglycosides. Klebseilla spp and Enterobacter were the 
2nd most common isolate organisms from this study found to 
be resistant to common antibiotics like amoxicillin and 
quinolones, cephalosporins. These were sensitive to 
fosfomycin and aminoglycosides. From the study it was 
clearly examine that susceptibility for quinolones was 51% 
(Ciprofloxacin, Norfloxacin, Nalidixic acid). Among 
cephalosporins, Ceftazidime and Ceftriaxone showed high 
susceptibility (75%) while cephalexin showed least 
susceptibility (43%). [42] 
Previous study at Nepal predicts that E.coli was the principal 
pathogens showed higher susceptibility to common antibiotics 
Ampicillin, Cotrimoxazole and norfloxacin. The study also 
explains that all the other previous studies reported that a high 
prevalence of resistance to Norfloxacin, Ampicillin and 
Ciprofloxacin but this study showed the different study that 
showed ciprofloxacin was sensitive towards Klebsiella 
pathogens. Pseudomonas aeruginosa, which is a common 
cause of hospital-acquired UTI, was less sensitive to the 
common antibiotics but highly sensitive to amikacin, 
piperacillin, ciprofloxacin and gentamicin. The 
cephalosporins, cephalexin showed low mean susceptibility 
(49.7%) but ceftazidime showed high mean susceptibility. The 
study finally concluded that antibiotic showed the variation in 
resistance and sensitivity towards the pathogens. [43] 
Another study at Nigeria determines that Ofloxacin, 
Gentamicin, Augmentin showed the sensitivity towards the 
micro organisms but Nitrofurantoin and Cetizidine have the 
least sensitivity. Cotrimoxazole and Amoxycillin 
demonstrated resistances. The study finally concluded that 
gram negative bacteria E.coli has the highly incidence value 
among all other organisms causing CAUTI and antibiotic 
sensitivity pattern test predicts that Ofloxacin and Gentamycin 
are the  most effective drugs against the micro organisms. [37] 
From the results of these studies finally concluded that 
pathogens show the resistance to mostly of 1st line antibiotic 
due to poorly prescribed antibiotic during and after 
catheterization. The sensitivity pattern against pathogens 
shows variations that differ due to genetic difference, 
environmental factors etc. 
So it is necessary to check out the patient reports for the 
antibiotic sensitivity pattern during and after the 
catheterization that helps in determining which pathogen 





The management of CAUTI is probably the topic of greatest 
interest for the clinicians. Most of the study concluded that 
antibiotic resistance occurs due to the poorly prescribed 
antibiotics during and after the catheterization or many other 
factors like inappropriate sterilisation of catheter and 
microbial contamination during insertion. For the management 
of CAUTI, Centers for Disease Control and Prevention (CDC) 
guideline includes: 
[1] Aseptic insertion of urinary catheters by properly trained 
personnel, using aseptic technique and sterile equipment (with 
an exception being that clean technique is appropriate for 
chronic intermittent catheterisation)  
[2] Proper urinary catheter maintenance with a sterile, closed 
drainage system permitting unobstructed urine flow. [44] 
For the management long term catheter changing supports by 
most of the evidence. The previous study in 2000 by Raz et al 
reported that changing the long term catheter led to improved 
clinical and microbiological outcomes. Bacteriuria 
disappeared among most of the subjects by changing 
technique. Their hypothesis for the improved clinical 
outcomes with catheter change was that removal of the 
“bioburden” of the catheter-associated biofilm helped decrease 
the severity of inflammation and the probability of recurrence. 
[39] 
Another clinical question for the management of CAUTI is the 
duration of antibiotics necessary to treat CAUTI. The previous 
studies concluded that the appropriate duration of therapy for 
CAUTI lies between 3 and 14 days, and the duration of 
catheterization is likely to be an important variable in 
determining the optimal duration of therapy. [39] 
The management of patient is necessary to prevent the risk 
associated CAUTI and from the complications during and 
after the catheterization. The antibiotic sensitivity pattern test 
very much helpful in determining the pathogen and sensitive 
antibiotic against that pathogen. It is also necessary to 
determine the resistance of antibiotics in the patient that can 




It is hoped that medical technology will allow the 
advancement in catheterization procedures, need and duration 
for catheterization and provide advance improvements in the 
design of drainage system of urinary catheter. Biomaterial 
research is an exploding new science, and research must 
continue with these new materials in respect to mucosal 
biocompatibility and effectiveness in reducing bacterial 
biofilm attachment. It is anticipated that new biomaterials will 
eventually reduce bacterial adherence and biofilm formation 
and subsequently decrease the rate of catheter-associated 
infection. New antibiotics being developed may be able to 
penetrate the bacterial biofilm and may be more effective in 
this and other prosthesis-related infections. Further studies are 
required to rationalize the use of antibiotics both to prevent 
and treat catheter-associated infection. For now the most 
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effective way to reduce the incidence of catheter-associated 
infection is to avoid indwelling Foley catheterization if at all 
possible, or at least to reduce the length of time the catheter 
remains in the bladder.  
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